|
JOSD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.78619999996666E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.355220E-04 |
| Normal-vs-Stage2 |
2.03239999996274E-06 |
| Normal-vs-Stage3 |
1.003360E-04 |
| Normal-vs-Stage4 |
1.821940E-03 |
| Stage1-vs-Stage2 |
1.987590E-02 |
| Stage1-vs-Stage3 |
5.414200E-01 |
| Stage1-vs-Stage4 |
9.074800E-01 |
| Stage2-vs-Stage3 |
7.353600E-02 |
| Stage2-vs-Stage4 |
5.691800E-02 |
| Stage3-vs-Stage4 |
7.398600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.237000E-04 |
| Normal-vs-AfricanAmerican |
6.648000E-02 |
| Normal-vs-Asian |
7.482200E-03 |
| Caucasian-vs-AfricanAmerican |
7.784400E-01 |
| Caucasian-vs-Asian |
8.536800E-01 |
| AfricanAmerican-vs-Asian |
7.460200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.18789999999469E-05 |
| Normal-vs-Female |
2.24070000000021E-05 |
| Male-vs-Female |
3.180800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.739300E-03 |
| Normal-vs-Age(41-60Yrs) |
8.8277999998887E-07 |
| Normal-vs-Age(61-80Yrs) |
8.72840000054609E-07 |
| Normal-vs-Age(81-100Yrs) |
3.649800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.995700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.782800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.991800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.669200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.263800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.637600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.974000E-01 |
| Classical-VS-Follicular |
3.8968828164343E-14 |
| Classical-VS-Other |
2.773800E-01 |
| Classical-VS-Normal |
2.838200E-03 |
| Tall-VS-Follicular |
4.7003000047674E-08 |
| Tall-VS-Other |
1.559620E-01 |
| Tall-VS-Normal |
4.280100E-02 |
| Follicular-VS-Other |
1.221610E-01 |
| Follicular-VS-Normal |
1.27430288543451E-11 |
| Other-VS-Normal |
4.862200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.93429980103133E-10 |
| Normal-vs-N1 |
4.024400E-03 |
| N0-vs-N1 |
2.801500E-02 |
|
|
